Although AD is characterized by both amyloid- and tau-based pathologies, P-tau is more strongly associated with neurodegeneration and cognitive decline; besides, we also find that PP is associated with brain atrophy and cognitive decline, suggesting that high PP may convey AD risk through its closer association with tau phosphorylation [8]. Here, MAPT is linked to Brain atrophy.